Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT02357654
PHASE4

GnRH for Luteal Support in IVF/ICSI/FET Cycles

Sponsor: University Reproductive Associates

View on ClinicalTrials.gov

Summary

During IVF cycles an embryo is generally placed into the uterine cavity between 3 and 5 days after fertilization. For a successful pregnancy to take place, that embryo must then implant in the properly primed and staged endometrium, which subsequently must continue to develop to accommodate the growing and maturing embryo and then fetus. This process is normally regulated by hormonal interactions between the fetal, endometrial and luteal tissue. It has been found that after IVF additional support for the endometrium with progesterone improves implantation and subsequent live birth rates in IVF cycle . Recent data has shown that additional supplementation with a single administration of a GnRH agonist around the time the time of embryo transfer may further enhance these rates .

Key Details

Gender

FEMALE

Age Range

18 Years - 40 Years

Study Type

INTERVENTIONAL

Enrollment

350

Start Date

2015-11

Completion Date

2026-07

Last Updated

2025-08-01

Healthy Volunteers

No

Conditions

Interventions

DRUG

GnRH

single shot of GnRH agonist

DRUG

placebo

placebo

Locations (1)

University Reproductive Associates

Hasbrouck Heights, New Jersey, United States